A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of Tygacil in the usual German hospital setting. The main
goals are: to assess the efficacy of Tygacil under usual care conditions (cure rate); to
assess the main side effects observed in daily medical practice (Safety of Tygacil); to
determine whether patients are optimally dosed with Tygacil (according to the label) and the
proportion of patients receiving a monotherapy versus combination therapy; to observe the
potential resistance development against Tygacil in Germany; to determine which antibiotic
agents are chosen for a combination therapy with Tygacil; to determine to which antibiotic
substance non-responders to Tygacil are switched; to assess the duration of the intravenous
therapy with Tygacil and to determine whether and which patients receive an oral antibiotic
substance after the therapy with Tygacil; to collect information on profile, comorbidities
and characteristics of patients treated with Tygacil.